Knowledge, perceptions, and readiness to use electronic pharmacy services among the Syrian population: A cross-sectional study - Top-Institutions - MDSpire

Knowledge, perceptions, and readiness to use electronic pharmacy services among the Syrian population: A cross-sectional study

  • By

  • Mohammad Basheer Alameer

  • Zahra Kabbani

  • Reem Alsamara

  • Rana Habeeb

  • Kenda Jawich

  • June 29, 2026

  • 0 min

Share

Top Institutions in Family Medicine

Brief introduction explaining scope and methodology.

  • #1

    International University for Science and Technology (IUST)
    International University for Science and Technology (IUST)

    Damascus, Syria

    Key Differentiators

    • Pharmacy

  • #2

    Primary Health Care Corporation
    Primary Health Care Corporation

    Doha, Qatar

    Key Differentiators

    • Primary Care

  • #3

    IRB Ouest II
    IRB Ouest II

    Angers, France

    Key Differentiators

    • Ethics Review

  • #4

    Hamad General Hospital
    Hamad General Hospital

    Doha, Qatar

    Key Differentiators

    • General Hospital

  • #5

    Hospital in Northern Sweden
    Hospital in Northern Sweden

    Northern Sweden, Sweden

    Key Differentiators

    • General Healthcare

Original Source(s)

Knowledge, perceptions, and readiness to use electronic pharmacy services among the Syrian population: A cross-sectional study

  • by Mohammad Basheer Alameer, Zahra Kabbani, Reem Alsamara, Rana Habeeb, Kenda Jawich

  • June 29, 2026

Related Content

FDA Approves Pediatric Risankizumab

Approval expands risankizumab use to pediatric plaque psoriasis and psoriatic arthritis and includes a new 55-mg prefilled syringe for weight-based dosing in patients weighing less than 40 kg.

Where Are Adults Getting Sunburned?

Water-related activities were the most commonly reported setting for recent sunburn, while more than one-half of respondents reported sunscreen use at the time of their most recent sunburn.

Early-Phase Data Support Novel Contrast Agent

ASE 2026 data support further development of MVT-100 in pivotal trials.